QurCan Therapeutics is a biotech company focused on developing next-generation RNA and chemotherapeutics enabled by its proprietary nanoparticle drug delivery system. QurCan’s next-generation drug delivery platform, TERP, overcomes the limitations of immunogenicity, stability and liver accumulation faced by existing lipid-based nanoparticles while offering advantages of higher safety, scalable manufacturing and site-specific delivery of therapeutics (RNAs and peptides) to address major unmet needs in cancer and CNS disorders. The company has a first-in-class cancer therapeutic at the IND-ready stage.

QurCan Therapeutics logo



Event details

Date: January 9 - 11, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


13 in total